NCT05598437 is a clinical trial of Dry eye device in Dryness, sponsored by Roweis adel youssef.

Who is sponsoring NCT05598437?

NCT05598437 is sponsored by Roweis adel youssef.

What drugs are being tested in NCT05598437?

Interventions in NCT05598437: Dry eye device.

What condition does NCT05598437 study?

NCT05598437 studies Dryness, Dry Eye Syndromes, Meibomian Gland Dysfunction.

Is NCT05598437 still recruiting?

NCT05598437 is currently status unknown. Last updated 28 October 2022.

Last reviewed 2022-10-28 · How we verify

NCT05598437

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence of Different Etiologies of Ocular Dryness in Patients Previously Diagnosed With Dry Eye Disease in A Sample of Egyptian Patients

Status unknown Last updated 28 October 2022

What this trial tests

trial testing Dry eye device in Dryness in 200 participants. Status unknown.

Timeline

1 November 2022

Primary endpoint
1 April 2023

30 April 2023

Quick facts

Lead sponsor	Roweis adel youssef
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 November 2022
Primary completion	1 April 2023
Estimated completion	30 April 2023
Sites	2 locations across Egypt

Drugs / interventions tested

Dry eye device

Conditions studied

Dryness — all drugs for Dryness →
Dry Eye Syndromes — all drugs for Dry Eye Syndromes →
Meibomian Gland Dysfunction — all drugs for Meibomian Gland Dysfunction →

Sponsor

Roweis adel youssef

Who can join

Adults 20 to 60, any sex, with Dryness or Dry Eye Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Proposed Study Title: Prevalence of Different Etiologies of Ocular Dryness in Patients Previously Diagnosed with Dry Eye

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05598437 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Roweis adel youssef
Last refreshed: 28 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05598437.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing